Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Longitudinal changes in each retinal layer thickness in diabetic retinopathy patients treated with pan-retinal photocoagulation

Abstract

Background/Objectives

To identify longitudinal changes in each retinal layer thickness in diabetic retinopathy (DR) patients who underwent pan-retinal photocoagulation (PRP).

Subjects/Methods

The subjects were divided into three groups: type 2 diabetes patients without DR (DM group), those with DR (DR group), and those who underwent PRP ≥ 6 months earlier (PRP group). Following the baseline visit, patients underwent three additional assessments at 1-year intervals.

Results

In total, 297 eyes were included: 87, 124, and 76 in the DM, DR, and PRP groups, respectively. The baseline ganglion cell complex (GCC) thickness was 110.4 ± 13.4, 112.5 ± 13.2, and 116.1 ± 17.6 μm in the DM, DR, and PRP groups, respectively (P = 0.047). The baseline thickness of inner nuclear layer (P = 0.026) and outer plexiform layer (P = 0.002) differed significantly, which was significantly thicker in the PRP group. The photoreceptor layer and retinal pigment epithelium thicknesses differed significantly among the groups (both P < 0.001), and those in the PRP group were significantly thinner than in the other groups. In the PRP group, there were significant decreases in GCC and outer nuclear layer (ONL) thickness over time, while the other layers did not change significantly. The GCC (estimate = −0.15, P = 0.012) and ONL (estimate = −0.16, P = 0.019) thicknesses were significantly associated with changes in best-corrected visual acuity.

Conclusions

The thickness of each retinal layer of patients who underwent PRP changed differently over time, and these changes were significantly associated with changes in visual acuity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Longitudinal changes in best-corrected visual acuity and retinal layer thickness in diabetic patients without diabetic retinopathy, with diabetic retinopathy, and after pan-retinal photocoagulation.

Similar content being viewed by others

Data availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diab Care. 2017;40:412.

    Article  Google Scholar 

  2. Group DRSR. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology. 1981;88:583–600.

    Article  Google Scholar 

  3. Network DRCR. Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Arch Ophthalmol. 2009;127:132–40.

    Article  Google Scholar 

  4. Shin JS, Lee YH. Changes in macular retinal layers and peripapillary nerve fiber layer thickness after 577-nm pattern scanning laser in patients with diabetic retinopathy. Korean J Ophthalmol. 2017;31:497.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lim HB, Shin YI, Lee MW, Koo H, Lee WH, Kim JY. Ganglion cell–inner plexiform layer damage in diabetic patients: 3-year prospective, longitudinal, observational study. Sci Rep. 2020;10:1470.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Vujosevic S, Muraca A, Gatti V, Masoero L, Brambilla M, Cannillo B, et al. Peripapillary microvascular and neural changes in diabetes mellitus: an OCT-angiography study. Investig Ophthalmol Vis Sci. 2018;59:5074–81.

    Article  Google Scholar 

  7. Lee M-W, Lee W-H, Ryu C-K, Kim T-Y, Lim H-B, Lee Y-H, et al. Effects of prolonged type 2 diabetes on the inner retinal layer and macular microvasculature: an optical coherence tomography angiography study. J Clin Med. 2020;9:1849.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Borrelli E, Barresi C, Feo A, Lari G, Grosso D, Querques L, et al. Imaging biomarkers and clinical factors associated with the rate of progressive inner and outer retinal thinning in patients with diabetic macular edema. Sci Rep. 2023;13:3224.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Li M, Tian M, Wang Y, Ma H, Zhou Y, Jiang X, et al. Updates on RPE cell damage in diabetic retinopathy. Mol Med Rep. 2023;28:1–8.

    Article  Google Scholar 

  10. Shimura M, Yasuda K, Nakazawa T, Abe T, Shiono T, Iida T, et al. Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. Graefe’s Arch Clin Exp Ophthalmol. 2009;247:1617–24.

    Article  CAS  Google Scholar 

  11. Simó R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia. 2018;61:1902–12.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Scholl S, Kirchhof J, Augustin AJ. Pathophysiology of macular edema. Ophthalmologica. 2010;224:8–15.

    Article  CAS  PubMed  Google Scholar 

  13. Sidorczuk P, Obuchowska I, Konopinska J, Dmuchowska DA. Correlation between choroidal vascularity index and outer retina in patients with diabetic retinopathy. J Clin Med. 2022;11:3882.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Sim DA, Keane PA, Fung S, Karampelas M, Sadda SR, Fruttiger M, et al. Quantitative analysis of diabetic macular ischemia using optical coherence tomography. Investig Ophthalmol Vis Sci. 2014;55:417–23.

    Article  Google Scholar 

  15. Paulus YM, Jain A, Gariano RF, Stanzel BV, Marmor M, Blumenkranz MS, et al. Healing of retinal photocoagulation lesions. Investig Ophthalmol Vis Sci. 2008;49:5540–5.

    Article  Google Scholar 

  16. Zhang Z, Meng X, Wu Z, Zou W, Zhang J, Zhu D, et al. Changes in choroidal thickness after panretinal photocoagulation for diabetic retinopathy: a 12-week longitudinal study. Investig Ophthalmol Vis Sci. 2015;56:2631–8.

    Article  Google Scholar 

  17. Mitsch C, Pemp B, Kriechbaum K, Bolz M, Scholda C, Schmidt-Erfurth U. Retinal morphometry changes measured with spectral domain-optical coherence tomography after pan-retinal photocoagulation in patients with proliferative diabetic retinopathy. Retina. 2016;36:1162–9.

    Article  CAS  PubMed  Google Scholar 

  18. Lascaratos G, Ji D, Wood JP, Osborne NN. Visible light affects mitochondrial function and induces neuronal death in retinal cell cultures. Vis Res. 2007;47:1191–201.

    Article  CAS  PubMed  Google Scholar 

  19. Sparrow JR, Zhou J, Ben-Shabat S, Vollmer H, Itagaki Y, Nakanishi K. Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE. Investig Ophthalmol Vis Sci. 2002;43:1222–7.

    Google Scholar 

  20. Sandbach JM, Coscun PE, Grossniklaus HE, Kokoszka JE, Newman NJ, Wallace DC. Ocular pathology in mitochondrial superoxide dismutase (Sod2)–deficient mice. Investig Ophthalmol Vis Sci. 2001;42:2173–8.

    CAS  Google Scholar 

  21. Kortuem K, Geiger LK, Levin LA. Differential susceptibility of retinal ganglion cells to reactive oxygen species. Investig Ophthalmol Vis Sci. 2000;41:3176–82.

    CAS  Google Scholar 

  22. Jackson GR, Barber AJ. Visual dysfunction associated with diabetic retinopathy. Curr Diab Rep. 2010;10:380–4.

    Article  PubMed  Google Scholar 

  23. Trento M, Durando O, Lavecchia S, Charrier L, Cavallo F, Costa MA, et al. Vision related quality of life in patients with type 2 diabetes in the EUROCONDOR trial. Endocrine. 2017;57:83–88.

    Article  CAS  PubMed  Google Scholar 

  24. Zhao H, Zhou L, Lai K, Yu M, Huang C, Xu F, et al. Comparison of functional changes of retina after subthreshold and threshold pan-retinal photocoagulation in severe non-proliferative diabetic retinopathy. Lasers Med Sci. 2022;37:3561–9.

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by Chungnam National University.

Author information

Authors and Affiliations

Authors

Contributions

Contributions to Authors in each of these areas Design and conduct of the study (MWL); Collection of data (MWL and JTK); Analysis and interpretation of data (MWL, JTK, and JYS); Writing the article (MWL, JTK, and JYS); Critical revision of the article (MWL, JTK, and JYS); Final approval of the article (MWL, JTK, and JYS).

Corresponding author

Correspondence to Min-Woo Lee.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self−archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sung, JY., Kim, JT. & Lee, MW. Longitudinal changes in each retinal layer thickness in diabetic retinopathy patients treated with pan-retinal photocoagulation. Eye 40, 376–382 (2026). https://doi.org/10.1038/s41433-025-04173-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41433-025-04173-7

Search

Quick links